Patel Chem Specialities Limited , a manufacturer of pharmaceutical excipients and specialty chemicals, has reported strong financial performance for the half-year ended September 30, 2025. The company's revenue and profit figures show significant growth compared to the previous half-year period.

Financial Highlights

The company's revenue from operations increased by 14.8%, reaching ₹6,115.81 lakhs in the first half of FY2026, up from ₹5,494.86 lakhs in the corresponding period of the previous fiscal year. This growth demonstrates the company's strong market position and demand for its products.

Notably, Patel Chem Specialities' net profit also saw a significant rise, growing from ₹534.11 lakhs to ₹612.92 lakhs, marking a 14.8% increase. This parallel growth in both revenue and profit suggests that the company has maintained its operational efficiency while expanding its business.

Corporate Communication Update

In addition to the financial results, the company issued a correction to a previous corporate announcement. Patel Chem Specialities rectified a typographical error regarding the date of financial results disclosure. This prompt correction reflects the company's commitment to accurate and transparent communication with its stakeholders.

The robust financial performance of Patel Chem Specialities Limited in the first half of FY2026 is noteworthy for investors and market watchers, particularly those focused on the pharmaceutical and specialty chemicals sectors.

Patel Chem Specialities Limited , a leading chemical company, has taken a significant step towards expanding its operations by signing a major turnkey project agreement. The company has executed an Independent Turnkey Project Service Agreement with J & H Pharma Consultants for their Indrad Plant, valued at Rs 45.00 crores.

Project Details

The agreement outlines a comprehensive project scope for J & H Pharma Consultants. As per the contract, the consultant will be responsible for:

• Designing
• Engineering
• Procuring
• Constructing
• Testing

The project aims to deliver a fully operational facility to Patel Chem Specialities upon completion.

Project Location

The Indrad Plant is strategically located at:

• Survey No. 68 (old block/Survey No.44 Paikee 1 Paikee 1 adm. 15885 Sq. Meter)
• Block/Survey No. 91 (old block/Survey No.44 Paikee 1 Paikee 2 adm. 7088 Sq. Meter)
• Mouje Village, Taluka Talod

Financial Implications

The total consideration for this turnkey project is set at Rs 45.00 crores, highlighting the substantial investment Patel Chem Specialities is making in its infrastructure and capabilities.

Regulatory Compliance

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Patel Chem Specialities has duly informed the BSE Limited about this significant development.

Independence of the Consultant

J & H Pharma Consultants is not related to the promoter or promoter group of Patel Chem Specialities. The company has explicitly stated that this transaction does not fall under related party transactions, ensuring transparency and adherence to corporate governance norms.

This strategic move by Patel Chem Specialities underscores the company's commitment to growth and operational excellence. The turnkey project is expected to enhance the company's manufacturing capabilities and potentially contribute to its long-term business objectives.